Interferon alpha 2-b therapy of HCV and NonBNonC chronic hepatitis
Twenty-four patients with HCV and NonBNonC chronic hepatitis—4 with HIV coinfection—were treated with r-IFN alpha for at least six months. In this period 62.5% of patients show a normalization of ALT but not a sustained remission. Non-responders have histologically more severe and long-lasting chronic hepatitis.
KeywordsChronic Hepatitis Sustained Remission Patient Risk Factor Alpha Interferon Therapy Recombinant Interferon Alpha
- 1.Davis GL, Baiart LA, Schiff ER et al (1989) Treatment of chronic hepatitis C with recombinant interferon alpha. A multicentric randomized controlled trial. N Engl J Med 22: 1501–1505Google Scholar